Studying why cancer treatments cause side effects
Part of Blood & lymphatic, Cancer clinical trials.
This study uses special cells grown in a lab to understand why some cancer treatments cause side effects. It may help researchers find ways to predict and prevent these side effects in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have had, are currently getting, or are scheduled to receive cancer treatment (such as chemotherapy, targeted therapy, or immunotherapy).
- You must be able to understand the study information and agree to follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the side effects (complications) and how well people respond when they receive anti-VEGF cancer medicines. It may help doctors better manage treatment and understand who benefits most.
This study tries to predict who is more likely to get serious side effects from immune checkpoint medicines used for solid tumors. You may help researchers by answering questionnaires before treatment and during follow-up, and by possibly storing sample specimens.
This study looks at side effects from immunotherapy in people with solid or blood cancers. It may help doctors better manage these side effects in the future.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
This study looks at how well current methods manage low blood cell counts (low platelets, low white blood cells, and low red blood cells) that can happen from targeted therapies for breast cancer. If you have breast cancer and are getting or have gotten a targeted therapy, this trial could help improve care for side effects like these.
This study looks at how people’s bodies respond to cancer immunotherapy and why some people get side effects. Your information and lab results may help improve how immunotherapy is managed in the future.
Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.